Literature DB >> 18034829

Roles of nuclear factor-kappaB in postischemic liver.

Thomas Shin1, Satoshi Kuboki, Alex B Lentsch.   

Abstract

Hepatic ischemia/reperfusion (I/R) results in a chain of events that culminate in liver dysfunction and injury. I/R injury is characterized by early oxidant stress followed by an intense acute inflammatory response that involves the transcription factor nuclear factor (NF)-kappaB. In addition to being a primary regulator of pro-inflammatory gene expression, NF-kappaB may play other roles in the hepatic response to I/R, such as mediating the expression of anti-apoptotic genes, preventing the accumulation of damaging reactive oxygen species, facilitating liver regeneration, and mediating the protective effects of ischemic preconditioning. In the present study, we review the diverse functions of NF-kappaB during hepatic I/R injury.

Entities:  

Year:  2007        PMID: 18034829     DOI: 10.1111/j.1872-034X.2007.00303.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  14 in total

1.  Accelerated proliferation of hepatocytes in rats with iron overload after partial hepatectomy.

Authors:  Shucai An; Kyaw Soe; Maki Akamatsu; Yoshitaka Hishikawa; Takehiko Koji
Journal:  Histochem Cell Biol       Date:  2012-07-24       Impact factor: 4.304

2.  Receptor activator of nuclear factor-κB ligand (RANKL) protects against hepatic ischemia/reperfusion injury in mice.

Authors:  Nozomu Sakai; Heather L Van Sweringen; Rebecca Schuster; John Blanchard; Justin M Burns; Amit D Tevar; Michael J Edwards; Alex B Lentsch
Journal:  Hepatology       Date:  2012-01-13       Impact factor: 17.425

3.  Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia-reperfusion injury.

Authors:  Takanori Konishi; Rebecca M Schuster; Alex B Lentsch
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-01-11       Impact factor: 4.052

4.  Abnormal modulation of cell protective systems in response to ischemic/reperfusion injury is important in the development of mouse sickle cell hepatopathy.

Authors:  Angela Siciliano; Giorgio Malpeli; Orah S Platt; Christophe Lebouef; Anne Janin; Aldo Scarpa; Oliviero Olivieri; Eliana Amato; Roberto Corrocher; Yves Beuzard; Lucia De Franceschi
Journal:  Haematologica       Date:  2010-09-17       Impact factor: 9.941

5.  Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice.

Authors:  Nozomu Sakai; Heather L Van Sweringen; R Cutler Quillin; Rebecca Schuster; John Blanchard; Justin M Burns; Amit D Tevar; Michael J Edwards; Alex B Lentsch
Journal:  Hepatology       Date:  2012-10       Impact factor: 17.425

6.  Portal vein ligation accelerates tumor growth in ligated, but not contralateral lobes.

Authors:  Nozomu Sakai; Callisia N Clarke; Rebecca Schuster; John Blanchard; Amit D Tevar; Michael J Edwards; Alex B Lentsch
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

7.  The peptidyl-prolyl isomerase, Pin1, facilitates NF-kappaB binding in hepatocytes and protects against hepatic ischemia/reperfusion injury.

Authors:  Satoshi Kuboki; Nozomu Sakai; Callisia Clarke; Rebecca Schuster; John Blanchard; Michael J Edwards; Alex B Lentsch
Journal:  J Hepatol       Date:  2009-05-24       Impact factor: 25.083

Review 8.  CXC chemokines play a critical role in liver injury, recovery, and regeneration.

Authors:  Callisia N Clarke; Satoshi Kuboki; Amit Tevar; Alex B Lentsch; Michael Edwards
Journal:  Am J Surg       Date:  2009-09       Impact factor: 2.565

9.  Age-related decrease in proteasome expression contributes to defective nuclear factor-kappaB activation during hepatic ischemia/reperfusion.

Authors:  Nadine Huber; Nozomu Sakai; Thorsten Eismann; Thomas Shin; Satoshi Kuboki; John Blanchard; Rebecca Schuster; Michael J Edwards; Hector R Wong; Alex B Lentsch
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

10.  Protective Mechanisms of Hypothermia in Liver Surgery and Transplantation.

Authors:  Pim B Olthof; Megan J Reiniers; Marcel C Dirkes; Thomas M van Gulik; Rowan F van Golen
Journal:  Mol Med       Date:  2015-11-03       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.